Ocular Therapeutix
OCUL
OCUL
72 hedge funds and large institutions have $128M invested in Ocular Therapeutix in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 75 → 72 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Holders
72
Holding in Top 10
3
Calls
$1.29M
Puts
$1.11M
Top Buyers
| 1 | +$3.26M | |
| 2 | +$1.86M | |
| 3 | +$1.46M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$970K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$687K |
Top Sellers
| 1 | -$7.8M | |
| 2 | -$1.75M | |
| 3 | -$1.35M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.29M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$422K |